Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 99,493 | 83,355 | 75,582 | 74,933 | 73,734 |
| Operating Income | -99,493 | -83,355 | -75,582 | -74,933 | -73,734 |
| Interest Expense | 1,289 | 1,459 | 314 | 0 | 0 |
| Other Income | -1,710 | 3,884 | 2,367 | 2,947 | 5,807 |
| Pre-tax Income | -102,492 | -80,930 | -73,529 | -71,986 | -67,927 |
| Net Income Continuous | -102,492 | -80,930 | -73,529 | -71,986 | -67,927 |
| Net Income | $-102,492 | $-80,930 | $-73,529 | $-71,986 | $-67,927 |
| EPS Basic Total Ops | -0.61 | -0.50 | -0.53 | -0.52 | -0.50 |
| EPS Basic Continuous Ops | -0.69 | -0.59 | -0.64 | -0.64 | -0.61 |
| EPS Diluted Total Ops | -0.61 | -0.50 | -0.53 | -0.52 | -0.50 |
| EPS Diluted Continuous Ops | -0.69 | -0.59 | -0.64 | -0.64 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.50 | -0.53 | -0.52 | -0.09 |
| EBITDA(a) | $-99,683 | $-82,581 | $-74,648 | $-75,248 | $-75,713 |